These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 8078414

  • 1. Interaction of tazobactam with Staphylococcus aureus PC1 beta-lactamase: a molecular modelling and enzyme kinetics study.
    Denny BJ, Toomer CA, Lambert PA.
    Microbios; 1994; 78(317):245-57. PubMed ID: 8078414
    [Abstract] [Full Text] [Related]

  • 2. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
    Chen CC, Smith TJ, Kapadia G, Wäsch S, Zawadzke LE, Coulson A, Herzberg O.
    Biochemistry; 1996 Sep 24; 35(38):12251-8. PubMed ID: 8823158
    [Abstract] [Full Text] [Related]

  • 3. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
    Banerjee S, Pieper U, Kapadia G, Pannell LK, Herzberg O.
    Biochemistry; 1998 Mar 10; 37(10):3286-96. PubMed ID: 9521648
    [Abstract] [Full Text] [Related]

  • 4. Elimination of the hydrolytic water molecule in a class A beta-lactamase mutant: crystal structure and kinetics.
    Zawadzke LE, Chen CC, Banerjee S, Li Z, Wäsch S, Kapadia G, Moult J, Herzberg O.
    Biochemistry; 1996 Dec 24; 35(51):16475-82. PubMed ID: 8987980
    [Abstract] [Full Text] [Related]

  • 5. Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure.
    Padayatti PS, Helfand MS, Totir MA, Carey MP, Hujer AM, Carey PR, Bonomo RA, van den Akker F.
    Biochemistry; 2004 Feb 03; 43(4):843-8. PubMed ID: 14744126
    [Abstract] [Full Text] [Related]

  • 6. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T, Bethel CR, Bonomo RA, Knox JR.
    Biochemistry; 2004 Nov 09; 43(44):14111-7. PubMed ID: 15518561
    [Abstract] [Full Text] [Related]

  • 7. Circularly permuted beta-lactamase from Staphylococcus aureus PC1.
    Pieper U, Hayakawa K, Li Z, Herzberg O.
    Biochemistry; 1997 Jul 22; 36(29):8767-74. PubMed ID: 9220963
    [Abstract] [Full Text] [Related]

  • 8. Probing the non-proline cis peptide bond in beta-lactamase from Staphylococcus aureus PC1 by the replacement Asn136 --> Ala.
    Banerjee S, Shigematsu N, Pannell LK, Ruvinov S, Orban J, Schwarz F, Herzberg O.
    Biochemistry; 1997 Sep 09; 36(36):10857-66. PubMed ID: 9283075
    [Abstract] [Full Text] [Related]

  • 9. Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis.
    Chen CC, Rahil J, Pratt RF, Herzberg O.
    J Mol Biol; 1993 Nov 05; 234(1):165-78. PubMed ID: 8230196
    [Abstract] [Full Text] [Related]

  • 10. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR, Hujer AM, Helfand MS, Bonomo RA.
    FEMS Microbiol Lett; 2004 May 01; 234(1):99-103. PubMed ID: 15109726
    [Abstract] [Full Text] [Related]

  • 11. A kinetic study on the interaction between tazobactam (a penicillanic acid sulphone derivative) and active-site serine beta-lactamases.
    Perilli M, Franceschini N, Bonfiglio G, Segatore B, Stefani S, Nicoletti G, Perez MM, Bianchi C, Zollo A, Amicosante G.
    J Enzyme Inhib; 2000 May 01; 15(1):1-10. PubMed ID: 10850951
    [Abstract] [Full Text] [Related]

  • 12. A bifunctional monocyclic beta-lactam cross-links across the active site of beta-lactamase.
    Ahluwalia R, Day RA, Nauss J.
    Biochem Biophys Res Commun; 1995 Jan 17; 206(2):577-83. PubMed ID: 7826374
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
    Mustafi D, Hofer JE, Huang W, Palzkill T, Makinen MW.
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May 17; 60(6):1279-89. PubMed ID: 15134725
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An engineered Staphylococcus aureus PC1 beta-lactamase that hydrolyses third-generation cephalosporins.
    Zawadzke LE, Smith TJ, Herzberg O.
    Protein Eng; 1995 Dec 17; 8(12):1275-85. PubMed ID: 8869640
    [Abstract] [Full Text] [Related]

  • 18. Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis.
    Park H, Brothers EN, Merz KM.
    J Am Chem Soc; 2005 Mar 30; 127(12):4232-41. PubMed ID: 15783205
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases.
    Maveyraud L, Pratt RF, Samama JP.
    Biochemistry; 1998 Feb 24; 37(8):2622-8. PubMed ID: 9485412
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.